Assessment of Patients with Hematuria Hematuria comes in two main varieties: gross and
microscopic. A wide range of ailments can lead to hematuria, and the central task is to rule …

Bladder cancer is one of the most financially burdensome cancers globally, from its
diagnostic to its terminal stages. The impact it imposes on patients and the medical …

RNA methylation modification is a key process in epigenetics that regulates
posttranscriptional gene expression. With advances in next-generation sequencing …

Background Ferroptosis is a newly found non-apoptotic forms of cell death that plays an
important role in tumors. However, the prognostic value of ferroptosis-related genes (FRG) in …

There is a great need to improve the outlook for people facing urinary bladder cancer,
especially for patients with invasive urothelial carcinoma (InvUC) which is lethal in 50% of …

Bladder cancer (BC) is one of the most common malignant tumors in the urinary system, and
its high recurrence rate causes a great economic burden to patients. Traditional diagnosis …

Background Non–muscle-invasive bladder cancer (NMIBC) is characterized by frequent
recurrence of the disease, which is difficult to predict. Objective To combine digital …

Background Biomarkers acquired from blood samples are easy to obtain and cost-effective,
have attracted considerable interest, and have been widely investigated. Inflammation plays …

Background Non-muscle-invasive bladder cancer (NMIBC) has a high recurrence rate and
muscle-invasive bladder cancer (MIBC) has unfavorable outcomes in urothelial bladder …

Purpose We assessed the prognostic value of systemic immune-inflammation index (SII) to
refine risk stratification of the heterogeneous spectrum of patients with non-muscle-invasive …